Ceribell

Ceribell Focuses on Making EEG Widely Accessible, More Efficient, and Cost-Effective. The company has developed and validated an FDA-approved instant EEG system that does not require EEG technicians or professional interpreters, enabling faster access to results and clinical decision-making. Any healthcare provider can set up the Ceribell EEG system within six minutes, offering a proprietary "brain stethoscope" feature that significantly simplifies EEG result interpretation by converting brain waves into sound, allowing seizures to be detected auditorily. Early diagnosis and targeted treatment of seizure patients, including non-convulsive seizures that can only be diagnosed via EEG, can substantially reduce mortality, secondary brain injury, hospital stays, and the risk of complications.